Nominated as the 'SUPERSTART Incubator' by the 2nd LG Open-Innovation Start-up Nurture Program

Global Joint License & Technical Assistance and Asset Validation of Aging-related Sarcopenia Treatment Candidate with KSB Tugen

Nominated as '2023 Korea AI Startup 100' in Healthcare Sector by The Korea Economic Daily X KT

MOU for AI-based Bio-Bigdata Commercialization with Hancomcarelink & 3BIGS

[Celltrion] joint R&D and SI agreements for genomics-based biomarker discovery.

Nominated as ‘Core 100’ by Seoul Investment Promotion Agency.

Nominated as a COREBIZ company by Korea SMEs Development Association.

Nominated for the 2nd IKMP (Invest Korea Marketplace) project in 2023, organized by KOTRA (Korea Trade-Investment Promotion Agency).

Chosen as the Global Innovation Center in Silicon Valley's PMF program, under the Korea Ministry of Science and ICT (MSIT)

Nominated as ‘Baby Unicorn 200’ by the Ministry of SMEs and Startups (MSS)

[National Project] Participated in the AI-Integrated Medical Imaging Diagnosis System Project.

- Participating company for the AI Voucher Support Project 2022.

- Participating company for the AI-Integrated Medical Imaging Diagnosis System Project (Femoral Fracture).

[Genomics Company] Licensing agreement for gastric cancer biomarkers.

- Winner, 2nd Place, of the Amgen Korea X Ministry of Health and Welfare 'Pitching Day’.

[Allico Pharmaceutical] MOU for joint development of AI-based new drug based on genomic cohort data.

- Winner, 1st Place, Novartis X Seoul City '3rd Health X Challenge Seoul’.

[Samjin Pharmaceutical] Joint research MOU for AI-based new drug development.

[National Project] Participated in the AI-Integrated Medical Imaging Diagnosis System project.

- Exclusive contract for the use of Genomic Cohort Data.

- Licensing agreement with Yonsei Medical Center.

- Changed the company name to BASGENBIO.

[DS Asset Management] Raised a Series A Funding Round.

[Ewha Medical Center] MOU for research on the Genomic Cohort and EMR data.

[Korea University Medical Center] MOU for research and development of an AI-based Precision Medical Convergence Platform.

[National Project] Participated in the AI-Integrated Medical Imaging Diagnosis System Project.

- Developed AI-based Genomic Data Analysis Tool at Yonsei University Graduate School of Public Health.

Joint R&D for genomic data at Yonsei Medical Center.

Established 2BKO, a joint-stock company.

Development of a Rare Disease Platform Project at Korea University.